Navigation Links
Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Date:5/24/2011

peline, 2011 63

Table 42: Retinal Vein Occlusion Therapeutics, Regeneron Pharmaceuticals, Retinal Vein Occlusion Pipeline, 2011 63

Table 43: Regeneron Pharmaceuticals Deals, 2009-2011 64

Table 44: Retinal Vein Occlusion Therapeutics, Global, Deals, 2008-2011 66

1.2 List of Figures

Figure 1: Eye Diagram Depicting Normal and Effected Blood Vessels 6

Figure 2: Recent Onset Central Retinal Vein Occlusion, Showing Extensive Hemorrhages in the Posterior Pole and Creating the "Blood and Thunder Appearance" 7

Figure 3: Peripheral Fundus View, Showing Hemorrhages Extending All Over the Fundus 7

Figure 4: Fluorescein Angiograph Showing Hypofluorescence Due to Hemorrhages in Retina 9

Figure 5: Treatment Algorithm for RVO 9

Figure 6: Preferred Treatment for Macular Edema Following BRVO 11

Figure 7: Preferred Treatment for Cystoid Macular Edema Following CRVO 11

Figure 8: Retinal Vein Occlusion Therapeutics Market, Global, Revenue ($m), 2005–2010 13

Figure 9: Retinal Vein Occlusion Therapeutics Market, Global, Forecast ($m), 2010–2017 14

Figure 10: Retinal Vein Occlusion Therapeutics Market, The US, Revenue ($m), 2005-2010 15

Figure 11: Retinal Vein Occlusion Therapeutics Market, The US, Forecast ($m), 2010–2017 16

Figure 12: Retinal Vein Occlusion Therapeutics Market, France, Revenue ($m), 2005–2010 17

Figure 13: Retinal Vein Occlusion Therapeutics Market, France, Forecast ($m), 2010–2017 18

Figure 14: Retinal Vein Occlusion Therapeutics Market, Germany, Revenue ($m), 2005–2010 19

Figure 15: Retinal Vein Occlusion Therapeutics Market, Germany, Forecast ($m), 2010–2017 20

Figure 16: Retinal Vein Occlusion Therapeutics Market, Italy, Revenue ($m), 2005–2010 21

Figure 17: Retinal Vein Occlusion Therapeutics Market, Italy, Forecast ($m), 2010–2017 22

Figure 18: Retinal V
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
2. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
3. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
4. Reportlinker Adds Advanced Digital Medical Equipment Products Market
5. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
6. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
7. Reportlinker Adds Orphan Drugs in Asia 2011
8. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
9. Reportlinker Adds The Outlook for Medical Devices in South East Asia
10. Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
11. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... INC. (NYSE: RMD ) today announced that it ... 30, 2014 results on Thursday, July 31, 2014, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
(Date:7/13/2014)... Athletes with a certain genetic make-up are prone ... research presented today at the American Orthopaedic Society for ... marks the first of its kind investigating a genetic ... that occur after a head injury. , “We ... (GT)n genotype were four times more likely to have ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress manufacturer ... gorgeous Quinceanera dresses . , In ... outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving to ... released dresses are made according to the latest ... , It is worthy of mention that ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular ... has released its new range of elegant Quinceanera ... available at discounted prices. Worldwide clients can enjoy this ... the company’s online shop, there are plenty of beautiful ... with great materials. MyDressCity.com’s hot items are prom gowns, ...
(Date:7/13/2014)... Texas (PRWEB) July 13, 2014 Epidemiologists ... aGVHD in the 6MM, from 8,062 diagnosed incident cases ... at an Annual Growth Rate (AGR) of 4.35%, during ... the highest number of diagnosed incident cases of aGVHD ... Spain will have the lowest number of diagnosed incident ...
Breaking Medicine News(10 mins):Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4
... stigma is powerful, pervasive and destructive," said Marlene Schwartz, a ... reactions to two prom photos.// , One showed a ... woman. The other was the same photo altered to show ... ,The volunteers took a quick look at one or ...
... may be much more likely to have asthma and a nighttime ... from Australia.// ,Doctors often use night cough as a guide ... the August issue of Chest, suggest it may be appropriate to ... ,"Night cough is often taken as a sign of the onset ...
... for cancer complain of feeling weak //and tried, and ... symptoms. A new study suggests that may not be ... with worse prognosis after radiotherapy, the doctors assumed the ... of the therapy, as well., ,Not so, report ...
... New research shows the same drugs you take to ... ,Researchers from the University of Pittsburgh followed more than ... than seven years. Results of the study show more ... cholesterol-lowering drugs developed breast cancer, while 2.1 percent of ...
... proved exercise reduces the risk of breast cancer, and now ... may lower a woman’s risk of developing breast carcinoma in ... into invasive breast cancer if left untreated. ,Researchers from ... 35 and 64 years old. More than 550 participants had ...
... Lung cancer is by far the biggest cancer killer around the ... survey researchers found that 38 percent of 626 patients they ... 61 percent of the black and 29 percent of the white ... air would cause it to spread., Most of the patients were ...
Cached Medicine News:Health News:False beliefs could cost cancer patients their lives 2
... Eppendorf expands its line of ... easy-to-use microcentrifuge features a certified aerosol-tight ... bowl design to reduce noise., ,Model ... offering optional rotors to accommodate microcentrifuge ...
The new BioZ Dx incorporates the world's most advanced impedance cardiography (ICG) technology and powerful reporting features to quickly and easily provide noninvasive hemodynamic parameters....
... Varicella-Zoster (VZ) test system is ... semi-quantitative detection of VZ IgG ... the indirect fluorescent antibody (IFA) ... or confirm a recent infection ...
Inquire...
Medicine Products: